This book puts the ethics, policy and politics of stem cells into context in a way that helps readers understand why past and current issues have developed the way they have and what the implications are for their work going forward. It also addresses emerging issues as the field progresses towards clinical and industrial uses.While there is a superabundance of material on the ethics of embryo use and questions of embryonic "personhood," there is little that covers what practicing scientists and managers need to know in order to plan and execute responsible research. Furthermore, researchers funded by the NIH are required to have ethics training as a condition of the grant. As such, this book is an essential resource to all of these pre-professional students whether they plan to move into industry, government or academia.
Rezensionen / Stimmen
From the book reviews:
"The book will appeal to ethicists and college professors who are interested in research ethics and/or ethical, legal, and social implications (ELSI) projects. The book also will be useful to a variety of students interested in law and bioethics, or who are planning to conduct RMR. . this book provides many interesting insights into RMR, and those in the intended audience likely will find it to be useful, relevant, and thought provoking." (Joseph T. Norris, Doody's Book Reviews, September, 2014)
Auflage
Softcover reprint of the original 1st ed. 2014
Sprache
Verlagsort
Zielgruppe
Illustrationen
2
2 farbige Abbildungen
VIII, 227 p. 2 illus. in color.
Maße
Höhe: 235 mm
Breite: 155 mm
Dicke: 13 mm
Gewicht
ISBN-13
978-1-4939-4345-6 (9781493943456)
DOI
10.1007/978-1-4614-9062-3
Schweitzer Klassifikation
Linda F. Hogle is Professor of Medical Social Sciences in the School of Medicine & Public Health at the University of Wisconsin-Madison and Fellow at the Wisconsin Institutes for Discovery. Her research includes analyses of social, ethical, and legal issues in emerging cell-based and biomedical engineering technologies, as well as concepts of risk in innovative science as understood by governance bodies. She has served as an advisor to several international research consortia focusing on stem cell and regenerative medicine. Contributors include:Sean P. Palecek, University of Wisconsin-Madison, Department of Chemical and Biological Engineering, WIDavid Schaffer, University of California-Berkeley, Department of Chemical and Biomolecular Engineering, CAPeter W. Zandstra, University of Toronto, Institute of Biomaterials and Biomedical Engineering, ON, Canada David B. Resnik, National Institute of Environmental Health Sciences, NCTania Bubela, University of Alberta, Department of Public Health Sciences, AB, CanadaAmrita Mishra, University of Alberta, Department of Public Health Sciences, AB, CanadaDebra J. H. Mathews, The Johns Hopkins University, Berman Institute of Bioethics, MDKevin E. Noonan, McDonnell Boehnen Hulbert & Berghoff LLP, ILPilar N. Ossorio, University of Wisconsin-Madison Law School, WIJessica von Reyn, University of Wisconsin-Madison Law School, WINancy M. P. King, Wake Forest University School of Medicine, Department of Social Sciences and Health Policy, NCAmritava Das, University of Wisconsin-Madison, Department of Chemical and Biological Engineering, WI
